Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
Clinical trial NCT04521296 · TERMINATED
Trial details
- NCT number
- NCT04521296
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2021-09-14
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.